US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 10, 2022 (4 years ago)

Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.

What was recalled

Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16

Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
68180-169-16
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1150-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Zileuton recalls

See all